Ana Duarte
Senior Research Fellow

Profile

Biography

Ana Duarte is a Research Fellow working in Economic Evaluation and Health Technology Assessment (HTA) . She joined CHE in November 2012 after studying the MSc in Health Economics at the University of York. Ana also holds a Pharmacy degree and a post-graduate diploma in Regulation and Evaluation of Medicines and Health Products from the University of Lisbon. She is a member of the National Institute for Health and Care Excellence (NICE) technology appraisal committee A since 2021.

Her research focuses on the development and application of decision analysis methods to inform HTA. Ana’s research has contributed extensively to the NICE technology and diagnostic appraisal programme, and collaborated with HTA agencies in Portugal and Colombia to develop HTA methods guidelines. Her research interests also include the economic evaluation of diagnostic and prognostic tests, and advanced therapy medicinal product.

Research

Projects

Methodological research:

• Research for supporting the routine collection of patient reported outcome measure for the National Clinical Audits for assessing cost-effectiveness

Applied research:

• Health Technology Assessment - A clinical and economic evaluation of screeningand diagnostic tests to identify and treat women with gestational diabetes: association between maternal risk factors, glucose levels, and adverse outcomes
• Health Technology Assessment - A randomised controlled trial of computerised cognitive behaviour therapy for the treatment of depression in primary care: The Randomised Evaluation of the Effectiveness and Acceptability of Computerised Therapy (REEACT) trial
• SMaRT oncology-2: a two arm parallel group randomised controlled trial to determine the effectiveness and cost-effectiveness of adding a complex intervention for major depressive disorder ('Depression Care for People with Cancer') to usual care, compared to usual care alone in cancer patients

Past Projects

• Single Technology Assessment for NICE - Aflibercept in combination with irinotecan and fluorouracil-based therapy for the treatment of metastatic colorectal cancer which has progressed following prior oxaliplatin-based chemotherapy
• Single Technology Assessment for NICE - Crizotinib for the treatment of previously treated non-small-cell lung cancer associated with an anaplastic lymphoma kinase (ALK) fusion gene

Research group(s)

• Economic evaluation of health technologies

Teaching

Postgraduate

Distance learning programme

Present

• The Postgraduate Certificate in Health Economics for Health Care Professionals - tutor for Module 3 Introduction for Health Care Evaluation

Past

• The Postgraduate Certificate in Health Economics for Health Care Professionals - tutor in Module 2 - Health Economics: Concepts and Analysis

Other teaching

Centre for Health Economics

• Decision analytic modelling for economic evaluation - Course tutor
• York Expert Workshops in the Socio Economic Evaluation of Medicines - Course tutor

External activities

Invited talks and conferences

• Duarte A. Clinical trials and economic evaluation. The Ministry of Health of Brazil, Brazilia. November 2014.
• Duarte A. Economic evaluation of cancer treatments: The NICE approach. 21st National Consultant Workshop on the Practical Management of Lung Cancer, Leeds. November 2014.